EMEA (Europe, Middle East and Africa) Anti-Migraine Drugs Market Report 2017

October 2017 | 114 pages | ID: E15A3B7463BPEN
QYResearch

Abstracts

In this report, the EMEA Anti-Migraine Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Anti-Migraine Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anti-Migraine Drugs market competition by top manufacturers/players, with Anti-Migraine Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Eli Lilly
• Abbott Laboratories
• Eisai
• Allergan
• Endo
• GlaxoSmithKline
• Impax Laboratories
• Pfizer
• AstraZeneca
• Bayer
• Johnson & Johnson
• Merck
• Teva
• Allergan
• Amgen

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Triptans
• Ergots
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Anti-Migraine Drugs for each application, including

• Women
• Men

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Anti-Migraine Drugs Market Report 2017

1 ANTI-MIGRAINE DRUGS OVERVIEW

1.1 Product Overview and Scope of Anti-Migraine Drugs
1.2 Classification of Anti-Migraine Drugs
  1.2.1 EMEA Anti-Migraine Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Anti-Migraine Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Triptans
  1.2.4 Ergots
  1.2.5 Others
1.3 EMEA Anti-Migraine Drugs Market by Application/End Users
  1.3.1 EMEA Anti-Migraine Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Women
  1.3.3 Men
1.4 EMEA Anti-Migraine Drugs Market by Region
  1.4.1 EMEA Anti-Migraine Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Anti-Migraine Drugs (2012-2022)
  1.5.1 EMEA Anti-Migraine Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Anti-Migraine Drugs Revenue and Growth Rate (2012-2022)

2 EMEA ANTI-MIGRAINE DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Anti-Migraine Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Anti-Migraine Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Anti-Migraine Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Anti-Migraine Drugs Sale Price by Players (2012-2017)
2.2 EMEA Anti-Migraine Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Anti-Migraine Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Anti-Migraine Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Anti-Migraine Drugs Sale Price by Type (2012-2017)
2.3 EMEA Anti-Migraine Drugs (Volume) by Application
2.4 EMEA Anti-Migraine Drugs (Volume and Value) by Region
  2.4.1 EMEA Anti-Migraine Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Anti-Migraine Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Anti-Migraine Drugs Sales Price by Region (2012-2017)

3 EUROPE ANTI-MIGRAINE DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Anti-Migraine Drugs Sales and Value (2012-2017)
  3.1.1 Europe Anti-Migraine Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Anti-Migraine Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Anti-Migraine Drugs Sales and Market Share by Type
3.3 Europe Anti-Migraine Drugs Sales and Market Share by Application
3.4 Europe Anti-Migraine Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Anti-Migraine Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Anti-Migraine Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Anti-Migraine Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ANTI-MIGRAINE DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Anti-Migraine Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Anti-Migraine Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Anti-Migraine Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Anti-Migraine Drugs Sales and Market Share by Type
4.3 Middle East Anti-Migraine Drugs Sales and Market Share by Application
4.4 Middle East Anti-Migraine Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Anti-Migraine Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Anti-Migraine Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Anti-Migraine Drugs Sales and Growth Rate (2012-2017)

5 AFRICA ANTI-MIGRAINE DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Anti-Migraine Drugs Sales and Value (2012-2017)
  5.1.1 Africa Anti-Migraine Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Anti-Migraine Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Anti-Migraine Drugs Sales and Market Share by Type
5.3 Africa Anti-Migraine Drugs Sales and Market Share by Application
5.4 Africa Anti-Migraine Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Anti-Migraine Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Anti-Migraine Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Anti-Migraine Drugs Sales and Growth Rate (2012-2017)

6 EMEA ANTI-MIGRAINE DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Eli Lilly
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anti-Migraine Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Abbott Laboratories
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Anti-Migraine Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbott Laboratories Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eisai
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Anti-Migraine Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eisai Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Allergan
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Anti-Migraine Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Allergan Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Endo
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Anti-Migraine Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Endo Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Anti-Migraine Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Impax Laboratories
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Anti-Migraine Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Pfizer
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Anti-Migraine Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 AstraZeneca
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Anti-Migraine Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Bayer
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Anti-Migraine Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Bayer Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Johnson & Johnson
6.12 Merck
6.13 Teva
6.14 Allergan
6.15 Amgen

7 ANTI-MIGRAINE DRUGS MANUFACTURING COST ANALYSIS

7.1 Anti-Migraine Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Migraine Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anti-Migraine Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Migraine Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ANTI-MIGRAINE DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Anti-Migraine Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Anti-Migraine Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Anti-Migraine Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Anti-Migraine Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Anti-Migraine Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Anti-Migraine Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Anti-Migraine Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Anti-Migraine Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Anti-Migraine Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Anti-Migraine Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anti-Migraine Drugs
Figure EMEA Anti-Migraine Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Anti-Migraine Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Triptans Product Picture
Figure Ergots Product Picture
Figure Others Product Picture
Figure EMEA Anti-Migraine Drugs Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Anti-Migraine Drugs by Application in 2016
Figure Women Examples
Table Key Downstream Customer in Women
Figure Men Examples
Table Key Downstream Customer in Men
Figure EMEA Anti-Migraine Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Anti-Migraine Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Anti-Migraine Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Anti-Migraine Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Anti-Migraine Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Anti-Migraine Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Anti-Migraine Drugs Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Anti-Migraine Drugs Sales Share by Players (2012-2017)
Figure 2016 Anti-Migraine Drugs Sales Share by Players
Figure 2017 Anti-Migraine Drugs Sales Share by Players
Figure EMEA Anti-Migraine Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Anti-Migraine Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Anti-Migraine Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Anti-Migraine Drugs Revenue Share by Players
Table 2017 EMEA Anti-Migraine Drugs Revenue Share by Players
Table EMEA Anti-Migraine Drugs Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Anti-Migraine Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Anti-Migraine Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Anti-Migraine Drugs by Type (2012-2017)
Figure EMEA Anti-Migraine Drugs Sales Market Share by Type (2012-2017)
Table EMEA Anti-Migraine Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Anti-Migraine Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Migraine Drugs by Type in 2016
Table EMEA Anti-Migraine Drugs Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Anti-Migraine Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Anti-Migraine Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Anti-Migraine Drugs by Application (2012-2017)
Figure EMEA Anti-Migraine Drugs Sales Market Share by Application in 2016
Table EMEA Anti-Migraine Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Anti-Migraine Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Anti-Migraine Drugs by Region (2012-2017)
Figure EMEA Anti-Migraine Drugs Sales Market Share in 2016
Table EMEA Anti-Migraine Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Anti-Migraine Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Anti-Migraine Drugs by Region (2012-2017)
Figure EMEA Anti-Migraine Drugs Revenue Market Share Regions in 2016
Table EMEA Anti-Migraine Drugs Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Anti-Migraine Drugs Revenue and Growth Rate (2012-2017)
Table Europe Anti-Migraine Drugs Sales (K Pcs) by Type (2012-2017)
Table Europe Anti-Migraine Drugs Market Share by Type (2012-2017)
Figure Europe Anti-Migraine Drugs Market Share by Type in 2016
Table Europe Anti-Migraine Drugs Sales (K Pcs) by Application (2012-2017)
Table Europe Anti-Migraine Drugs Market Share by Application (2012-2017)
Figure Europe Anti-Migraine Drugs Market Share by Application in 2016
Table Europe Anti-Migraine Drugs Sales (K Pcs) by Countries (2012-2017)
Table Europe Anti-Migraine Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Anti-Migraine Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Anti-Migraine Drugs Sales Market Share by Countries in 2016
Table Europe Anti-Migraine Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Anti-Migraine Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Anti-Migraine Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Anti-Migraine Drugs Revenue Market Share by Countries in 2016
Figure Germany Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Anti-Migraine Drugs Sales (K Pcs) by Type (2012-2017)
Table Middle East Anti-Migraine Drugs Market Share by Type (2012-2017)
Figure Middle East Anti-Migraine Drugs Market Share by Type (2012-2017)
Table Middle East Anti-Migraine Drugs Sales (K Pcs) by Applications (2012-2017)
Table Middle East Anti-Migraine Drugs Market Share by Applications (2012-2017)
Figure Middle East Anti-Migraine Drugs Sales Market Share by Application in 2016
Table Middle East Anti-Migraine Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Anti-Migraine Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Anti-Migraine Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Anti-Migraine Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Anti-Migraine Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Anti-Migraine Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Anti-Migraine Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Anti-Migraine Drugs Sales (K Pcs) by Type (2012-2017)
Table Africa Anti-Migraine Drugs Sales Market Share by Type (2012-2017)
Figure Africa Anti-Migraine Drugs Sales Market Share by Type (2012-2017)
Figure Africa Anti-Migraine Drugs Sales Market Share by Type in 2016
Table Africa Anti-Migraine Drugs Sales (K Pcs) by Application (2012-2017)
Table Africa Anti-Migraine Drugs Sales Market Share by Application (2012-2017)
Figure Africa Anti-Migraine Drugs Sales Market Share by Application (2012-2017)
Table Africa Anti-Migraine Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Anti-Migraine Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Anti-Migraine Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Anti-Migraine Drugs Sales Market Share by Countries in 2016
Table Africa Anti-Migraine Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Anti-Migraine Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Anti-Migraine Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Anti-Migraine Drugs Revenue Market Share by Countries in 2016
Figure South Africa Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Eli Lilly Anti-Migraine Drugs Basic Information List
Table Eli Lilly Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eli Lilly Anti-Migraine Drugs Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Anti-Migraine Drugs Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories Anti-Migraine Drugs Basic Information List
Table Abbott Laboratories Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abbott Laboratories Anti-Migraine Drugs Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Anti-Migraine Drugs Revenue Market Share in EMEA (2012-2017)
Table Eisai Anti-Migraine Drugs Basic Information List
Table Eisai Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eisai Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eisai Anti-Migraine Drugs Sales Market Share in EMEA (2012-2017)
Figure Eisai Anti-Migraine Drugs Revenue Market Share in EMEA (2012-2017)
Table Allergan Anti-Migraine Drugs Basic Information List
Table Allergan Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Allergan Anti-Migraine Drugs Sales Market Share in EMEA (2012-2017)
Figure Allergan Anti-Migraine Drugs Revenue Market Share in EMEA (2012-2017)
Table Endo Anti-Migraine Drugs Basic Information List
Table Endo Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Endo Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Endo Anti-Migraine Drugs Sales Market Share in EMEA (2012-2017)
Figure Endo Anti-Migraine Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Anti-Migraine Drugs Basic Information List
Table GlaxoSmithKline Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Anti-Migraine Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Anti-Migraine Drugs Revenue Market Share in EMEA (2012-2017)
Table Impax Laboratories Anti-Migraine Drugs Basic Information List
Table Impax Laboratories Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Impax Laboratories Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Impax Laboratories Anti-Migraine Drugs Sales Market Share in EMEA (2012-2017)
Figure Impax Laboratories Anti-Migraine Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Anti-Migraine Drugs Basic Information List
Table Pfizer Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Anti-Migraine Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Anti-Migraine Drugs Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Anti-Migraine Drugs Basic Information List
Table AstraZeneca Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure AstraZeneca Anti-Migraine Drugs Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Anti-Migraine Drugs Revenue Market Share in EMEA (2012-2017)
Table Bayer Anti-Migraine Drugs Basic Information List
Table Bayer Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bayer Anti-Migraine Drugs Sales Market Share in EMEA (2012-2017)
Figure Bayer Anti-Migraine Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Anti-Migraine Drugs Basic Information List
Table Merck Anti-Migraine Drugs Basic Information List
Table Teva Anti-Migraine Drugs Basic Information List
Table Allergan Anti-Migraine Drugs Basic Information List
Table Amgen Anti-Migraine Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Migraine Drugs
Figure Manufacturing Process Analysis of Anti-Migraine Drugs
Figure Anti-Migraine Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Migraine Drugs Major Manufacturers in 2016
Table Major Buyers of Anti-Migraine Drugs
Table Distributors/Traders List
Figure EMEA Anti-Migraine Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Anti-Migraine Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Anti-Migraine Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Anti-Migraine Drugs Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Anti-Migraine Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Anti-Migraine Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Anti-Migraine Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Anti-Migraine Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Anti-Migraine Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Anti-Migraine Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Anti-Migraine Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Anti-Migraine Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Anti-Migraine Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Anti-Migraine Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Anti-Migraine Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Anti-Migraine Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Anti-Migraine Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Anti-Migraine Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Anti-Migraine Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Anti-Migraine Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Anti-Migraine Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Anti-Migraine Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Anti-Migraine Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources